Skip to content

Clinical trials

Withdrawn Smoldering Multiple Myeloma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Smoldering Multiple Myeloma Status: Withdrawn Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20121
20141
20191
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Case Comprehensive Cancer Center1
City of Hope Medical Center1
Meir Medical Center1
National Cancer Institute (NCI)1
Wake Forest University Health Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Smoldering Multiple Myeloma5
Monoclonal Gammopathy of Undetermined Significance2
Multiple Myeloma2
Hematologic Neoplasms1
Influenza, Human1
Leukemia, Lymphocytic, Chronic, B-Cell1
Lymphocytosis1
Lymphoma, B-Cell1
Lymphoma, Non-Hodgkin1
Neoplasms, Plasma Cell1

Trials

Showing 76 to 5 of 5. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.